Skip to content

Author

B. Milašinović

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access 2026

Safety of adalimumab in inflammatory bowel disease: Insights from a clinical cohort

Real-world data on the safety of adalimumab are essential for ongoing pharmacovigilance, while long-term evidence remains limited. This study aimed to evaluate adverse events (AEs) and their temporal patterns in a cohort of patients with inflammatory bowel disease (IBD). A retrospective observational study included 217...

B. Milašinović, S. Marković, S. Vezmar Kovačević et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.